%0 Journal Article %T Perioperative outcomes and lymph node assessment after induction therapy in patients with clinical N1 or N2 non-small cell lung cancer %A Carla C. Moodie %A Emily Ng %A Eric M. Toloza %A Frank O. Velez-Cubian %A Jacques P. Fontaine %A Jessica Glover %A Joseph R. Garrett %A Kavian Toosi %J SCIE-indexed Journal %D 2016 %R 10.21037/jtd.2016.07.09 %X Non-small cell lung cancer (NSCLC) represents a diverse group of tumor histologies, including squamous cell carcinoma, adenocarcinoma, and large-cell neuroendocrine carcinoma. Multiple trials have been conducted to determine the role and safety of induction chemotherapy (ICTx) with or without radiation in patients with resectable stage-2 or stage-3 NSCLC. While these trials tend to agree on the safety of induction therapy, surgery in addition to ICTx with or without radiation therapy (RT) in resectable lymph node (LN)-positive lung cancers has only relatively recently been shown to provide an overall survival benefit (1-5) %U http://jtd.amegroups.com/article/view/8818/html